The antitumor effects of Angelica sinensis on malignant brain tumors in vitro and in vivo

Clinical Cancer Research

Volumn 11, Issue 9, 2005, Pages 3475-3484

  Tsai, Nu Man ^a,b   Lin, Shinn Zong ^a,b   Lee, Chau Chin ^b   Chen, Shee Ping ^a,b   Su, Hsuan Chi ^b   Chang, Wen Liang ^c   Harn, Horng Jyh ^a,b  

^a TZU CHI UNIVERSITY   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGELICA SINENSIS EXTRACT; CARMUSTINE; CHLOROFORM; CYCLIN DEPENDENT KINASE INHIBITOR; PACLITAXEL; PROTEIN P21; RETINOBLASTOMA PROTEIN;

ANGELICA SINENSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BRAIN CANCER; CANCER INHIBITION; CANCER SURVIVAL; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CHINESE MEDICINE; CONTROLLED STUDY; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; TRADITIONAL MEDICINE; TUMOR VOLUME;

ANGELICA SINENSIS; ANIMALS; APOPTOSIS; BALB 3T3 CELLS; BRAIN NEOPLASMS; CASPASE 3; CASPASE 8; CASPASES; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; CHLOROFORM; ENZYME ACTIVATION; GLIOBLASTOMA; HL-60 CELLS; HUMANS; IN SITU NICK-END LABELING; KI-67 ANTIGEN; MALE; MICE; MICE, NUDE; PHOSPHORYLATION; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, INBRED F344; RETINOBLASTOMA PROTEIN; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 18244390977     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-1827     Document Type: Article

References (44)

1. Ross BD, Zhao YJ, Neal ER, et al. Contributions of cell kill and posttreatment tumor growth rates to the repopulation of intracerebral 9L tumors after chemotherapy: An MRI study. Proc Natl Acad Sci U S A 1998;95:7012-7.
2. Mahaley SJ, Mettlin C, Natarajan N, Laws RJ, Peace BB. National survey of patterns of care for brain-tumor patients. J Neurosurg 1989;71:826-36.
3. Santarius T, Kirsch M, Rossi ML, Black PM. Molecular aspects of neuro-oncology. Clin Neural Neurosurg 1997;99:184-95.
4. Cobb MA, Husain M, Andersen BJ, al-Mefty O. Significance of proliferating cell nuclear antigen in predicting recurrence of intracranial meningioma. J Neurosurg 1996;84:85-90.
5. Giese A, Bjerkvig R, Berens ME, Westphal M. Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol 2003;21: 1624-36.
6. Blacklock JB, Wright DC, Dedrick RL, et al. Drug streaming during intra-arterial chemotherapy. J Neurosurg 1986;64:248-91.
7. Shapiro WR, Green SB. Reevaluating the efficacy of intra-arterial BCNU. J Neurosurg 1987;66:313-5.
8. Elliott PJ, Hayward NJ, Huff MR, Nagle TL, Black KL, Bartus RT. Unlocking the blood-brain barrier: a role for RMP-7 in brain tumor therapy. Exp Neurol 1996;141: 214-24.
9. Bello L, Carrabba G, Giussani C, et al. Low-dose chemotherapy combined with an anti-angiogenic drug reduces human glioma growth in vivo. Cancer Res 2001;61:7501-6.
10. Nicholas MK, Prados MD, Larson D, Black PM, Loeffler J. Malignant astrocytomas in cancer of the nervous system. Oxford (United Kingdom): Blackwell Publishers: 1997. p. 464-91.
11. Boiardi A, Silvani A, Milanesi I, Botturi M, Broggi G. Primary glial tumor patients treated by combining cisplatin and etoposide. J Neurooncol 1991;11:165-70.
12. Jeremic B, Grujicic D, Jevremovic S, et al. Carboplatin and etoposide chemotherapy regimen for recurrent malignant glioma: a phase II study. J Clin Oncol 1992; 10:1074-7.
13. Stewart DJ. A critique of the role of the blood-brain barrier in the chemotherapy of human brain tumors. J Neurooncol 1994;20:121-39.
14. White L, Sterling-Levis K, Fisher R, Tobias V. Response of brain tumors to chemotherapy, evaluated in a clinically relevant xenograft model. J Neurooncol 1995;25:39-47.
15. Bonham M, Arnold H, Montgomery B, Nelson PS. Molecular effects of the herbal compound PC-SPES: identification of activity pathways in prostate carcinoma. Cancer Res 2002;62:3920-42.
16. Hu H, Ahn NS, Yang X, Lee YS, Kang KS. Ganoderma lucidum extract induces cell cycle arrest and apoptosis in MCF-7 human breast. Int J Cancer 2002;102:250-3.
17. 1 arrest. Life Sci 2001;69:1485-96.
18. Lee SM, Li ML, Tse YC, et al. Paeoniae Radix, a Chinese herbal extract, inhibits hepatoma cell growth by inducing apoptosis in a p53 independent pathway. Life Sci 2002:71:2267-77.
19. 1 phase. Cancer Res 54:448-54.
20. Huerta S, Arteaga JR, Irwin RW, Ikezoe T, Heber D, Koeffler HP. PC-SPES inhibits colon cancer growth in vitro and In vivo. Cancer Res 2002;62:5204-9.
21. Yim TK, Wu WK, Pak WF, Mak DH, Liang SM, Ko KM. Myocardial protection against ischaemia-reperfusion injury by a Polygonum multiflorum extract supplemented "Dang-Gui decoction for enriching blood," a compound formulation, ex vivo. Phytother Res 2002;14:195-9.
22. Ye YN, Koo MW, Li Y, Matsui H, Cho CH. Angelica sinensis modulates migration and proliferation of gastric epithelial cells. Life Sci 2001;68:961-8.
23. Ye YN, Liu ES, Li Y, et al. Protective effect of polysaccharides-enriched fraction from Angelica sinensis on hepatic injury. Life Sci 2001;69:637-46.
24. Ye YN, Liu ES, Shin VY, et al. A mechanistic study of proliferation induced by Angelica sinensis in a normal gastric epithelial cell line. Biochem Pharmacol 2001; 61:1439-48.
25. Ye YN, So HL, Liu ES, Shin VY, Cho CH. Effect of polysaccharides from Angelica sinensis on gastric ulcer healing. Life Sci 2003;72:925-32.
26. Abebe W. Herbal medication: potential for adverse interactions with analgesic drugs. J Clin Pharm Ther 2002;27:391-401.
27. Cheng YL, Chang WL, Lee SC, et al. Acetone extract of Bupleurum scorzonerifolium inhibits proliferation of A549 human lung cancer cells via inducing apoptosis and suppressing telomerase activity. Life Sci 2003;73:2383-94.
28. Cheng YL, Chang WL, Lee SC, et al. Acetone extract of Angelica sinensis inhibits proliferation of human cancer cells via inducing cell cycle arrest and apoptosis. Life Sci 2004;75:1579-94.
29. Lin KH, Wang WJ, Wu YH, Cheng SY. Activation of antimetastatic Nm23-H1 gene expression by estrogen and its α-receptor. Endocrinology 2002; 143:467-75.
30. Lee KJ, Mao S, Sun C, et al. Phage-display selection of a human single-chain fv antibody highly specific for melanoma and breast cancer cells using a chemoenzymatically synthesized G (M3)-carbohydrate antigen. J Am Chem Soc 2002;124:12439-46.
31. Santini D, Vincenzi B, Tonini G, Scarpa S, Baldi A. Zoledronic acid exhibits inhibitory effects on osteoblastic and osteolytic metastases of prostate cancer. Clin Cancer Res 2003;9:295-306.
32. Bhujwalla ZM, Artemov D, Natarajan K, Solaiyappan M, Kollars P, Kristjansen EG. Reduction of vascular and permeable regions in solid tumors detected by macromolecular contrast magnetic resonance imaging after treatment with antiangiogenic agent TNP-4701. Clin Cancer Res 2003;9:355-62.
33. Kruse CA, Mitchell DH, Kleinschmidt-DeMasters BK, et al. Characterization of a continuous human glioma cell line DBTRG-05MG: growth kinetics, karyotype, receptor expression, and tumor suppressor gene analyses. In Vitro Cell Dev Biol 1992;28:609-14.
34. Bowers G, He J, Schulz K, Olivarria G, Maneval D, Olson JJ. Efficacy of adenoviral p53 delivery with SCH58500 in the intracranial 9I and RG2 models. From Biosci 2003;8:54-61.
35. Schlegel J, Piontek G, Kersting M, et al. The p16/Cdkn2a/Ink4a gene is frequently deleted in nitrosourea-induced rat glial tumors. Pathobiology 1999; 67:202-6.
36. Belanich M, Pastor M, Randall T, et al. Retrospective study of the correlation between the DNA repair protein alkyltransferase and survival of brain tumor patients treated with carmustine. Cancer Res 1996; 56:783-8.
37. Kornblith PL, Walker M. Chemotherapy for malignant gliomas. J Neurosurg 1988;68:1-17.
38. 1 cyclin-dependent kinases. Genes Dev 1995;9: 1149-63.
39. 1 control in mammalian cells. J Cell Sci Suppl 1994;18:69-73.
40. Dobashi Y, Takehana T, Ooi A. Perspectives on cancer therapy: cell cycle blockers and perturbators. Curr Med Chem 2003;10:2549-58.
41. Bardon S, Foussard V, Fournel S, Loubat A. Monoterpenes inhibit proliferation of human colon cancer cells by modulating cell cycle-related protein expression. Cancer Lett 2002;181:187-94.
42. Fukuoka K, Yamagishi T, Ichihara T, et al. Mechanism of action of aragusterol a (YTA0040), a potent antitumor marine steroid targeting the G (1) phase of the cell cycle. Int J Cancer 2000;88:810-9.
43. 1 arrest checkpoint in response to DNA damage. Mol Cell Biol 1998;18:378-87.
44. Shang P, Qian AR, Yang TH, et al. Experimental study of anti-tumor effects of polysaccharides from Angelica sinensis. World J Gastroenterol 2003;9:1963-7.